A detailed history of Everence Capital Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Everence Capital Management Inc holds 5,344 shares of VRTX stock, worth $2.69 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,344
Previous 5,344 -0.0%
Holding current value
$2.69 Million
Previous $2.1 Million 18.39%
% of portfolio
0.16%
Previous 0.15%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$343.0 - $410.68 $1.02 Million - $1.22 Million
-2,980 Reduced 35.8%
5,344 $2.17 Million
Q1 2023

Apr 04, 2023

SELL
$283.23 - $323.1 $705,242 - $804,519
-2,490 Reduced 23.03%
8,324 $2.62 Million
Q4 2022

Jan 31, 2023

BUY
$285.76 - $321.48 $1.15 Million - $1.3 Million
4,030 Added 59.4%
10,814 $3.12 Million
Q2 2022

Jul 26, 2022

BUY
$234.96 - $292.55 $253,756 - $315,954
1,080 Added 18.93%
6,784 $1.91 Million
Q1 2022

Apr 11, 2022

SELL
$221.42 - $260.97 $347,629 - $409,722
-1,570 Reduced 21.58%
5,704 $1.49 Million
Q3 2021

Oct 21, 2021

BUY
$181.39 - $202.99 $284,782 - $318,694
1,570 Added 27.52%
7,274 $1.32 Million
Q3 2020

Feb 01, 2021

SELL
$255.65 - $303.1 $46,017 - $54,558
-180 Reduced 3.06%
5,704 $1.55 Million
Q4 2017

Feb 02, 2018

SELL
$137.28 - $155.55 $154,851 - $175,460
-1,128 Reduced 16.09%
5,884 $882,000
Q3 2017

Oct 31, 2017

BUY
$148.13 - $162.24 $1.04 Million - $1.14 Million
7,012
7,012 $1.07 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.